These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 319579)

  • 21. Topical immunosuppression in skin grafting with FK 506 ointment.
    Yuzawa K; Taniguchi H; Seino K; Otsuka M; Fukao K
    Transplant Proc; 1996 Jun; 28(3):1387-9. PubMed ID: 8658707
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of ampicillin on skin graft survival and antibody response in B6A F1 mice.
    Mościcka-Wesołowska M; Skopińska-Rózewska E
    Arch Immunol Ther Exp (Warsz); 1981; 29(3):379-83. PubMed ID: 7027991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prolongation of transplantation survival time by a PUVA treatment. Experimental and clinical results].
    Gruner S; Oesterwitz H; Kaden J; Meffert H
    Z Exp Chir Transplant Kunstliche Organe; 1990; 23(1):32-4. PubMed ID: 2220001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Xenogeneic (rat to mouse) skin tolerance induced by monoclonal antibodies, xenogeneic cells, and cyclophosphamide.
    Umesue M; Mayumi H; Nishimura Y; Kong YY; Omoto K; Murakami Y; Nomoto K; Nomoto K
    Transplant Proc; 1995 Feb; 27(1):315-6. PubMed ID: 7879018
    [No Abstract]   [Full Text] [Related]  

  • 25. Genetic control of permanently accepted allografts.
    Adelmann A; Sherburne C; Condie RM; Click RE
    Transplant Proc; 1987 Feb; 19(1 Pt 1):890-3. PubMed ID: 3547845
    [No Abstract]   [Full Text] [Related]  

  • 26. Different efficiency of mercurascan in allograft survival prolongation in male and female mice.
    Hilgert I; Pokorná Z; Singh K; Kolc J; Kristofová H; Málek P
    Folia Biol (Praha); 1981; 27(6):379-87. PubMed ID: 7035230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Miconazole prolongs murine skin graft survival.
    Thong YH; Ferrante A
    Clin Exp Immunol; 1979 Jan; 35(1):10-2. PubMed ID: 371878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolongation of skin allograft survival in mice by didemnin B.
    Alfrey EJ; Zukoski CF; Montgomery DW
    Transplantation; 1992 Jul; 54(1):188-9. PubMed ID: 1631937
    [No Abstract]   [Full Text] [Related]  

  • 29. Marked prolongation of incompatible class I deficient heart allografts: paradoxical effects between primarily and secondarily vascularized allografts.
    Henretta J; Araneda D; Pittman K; Thomas F
    Transplant Proc; 1995 Feb; 27(1):1303-4. PubMed ID: 7878892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo treatment of mice with heat shock protein, gp 96, improves survival of skin grafts with minor and major antigenic disparity.
    Kovalchin JT; Mendonca C; Wagh MS; Wang R; Chandawarkar RY
    Transpl Immunol; 2006 Jan; 15(3):179-85. PubMed ID: 16431284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolonged survival of allogeneic mouse skin grafts following preservation.
    Cohen I; Yemini M; Wexler MR; Brautbar H
    Isr J Med Sci; 1980; 16(9-10):628-30. PubMed ID: 7000732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alpha-1 antitrypsin treatment of spontaneously diabetic nonobese diabetic mice receiving islet allografts.
    Pileggi A; Molano RD; Song S; Zahr E; SanJose S; Villate S; Wasserfall C; Ricordi C; Atkinson MA; Inverardi L
    Transplant Proc; 2008 Mar; 40(2):457-8. PubMed ID: 18374100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Active enhancement of donor-strain skin in mice bearing H-2D-incompatible heart allografts.
    Corry RJ; Kelley SE
    Transplant Proc; 1977 Mar; 9(1):945-9. PubMed ID: 325825
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of anti-H-2K and H-2D alloantibodies in enhancement and acute antibody-mediated rejection of mouse skin allografts.
    de Waal RM; Capel PJ; Koene RA
    J Immunol; 1980 Feb; 124(2):719-23. PubMed ID: 6985936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of different survival of weakly incompatible allografts of skin from the ear and back.
    Polácková M; Viklický V
    Folia Biol (Praha); 1976; 22(5):363-5. PubMed ID: 791693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of lentil lectin treatment on the survival of rat skin allografts in strain combinations with different genetic disparity.
    Hilgert I; Kristofová H; Kren V; Panczak A
    Folia Biol (Praha); 1984; 30(2):104-8. PubMed ID: 6373390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extended skin allo- and xenograft survival in mice treated with rapamycin, antilymphocyte serum, and donor-specific bone marrow transfusion.
    Hale DA; Gottschalk R; Fukuzaki T; Wood ML; Maki T; Monaco AP
    Transplant Proc; 1996 Dec; 28(6):3269. PubMed ID: 8962269
    [No Abstract]   [Full Text] [Related]  

  • 38. A rat anti-mouse CD3 monoclonal antibody induces long-term skin allograft survival without inducing side effects.
    Vossen AC; Tibbe GJ; van Oudenaren A; Vredendaal AE; Benner R; Savelkoul HF
    Transplant Proc; 1994 Dec; 26(6):3157-8. PubMed ID: 7998101
    [No Abstract]   [Full Text] [Related]  

  • 39. Survival of skin allografts is prolonged in mice with a dominant-negative H-Ras.
    Funeshima-Fuji N; Fujino M; Kimura H; Takahara S; Nakayama T; Ezaki T; Li XK
    Transpl Immunol; 2008 Feb; 18(4):302-6. PubMed ID: 18158115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Operational tolerance in nonvascularized transplant models induced by AR-C117977, a monocarboxylate transporter inhibitor.
    Påhlman C; Malm H; Qi Z; Veress B; Ferguson D; Bundick R; Murray C; Donald D; Ekberg H
    Transplantation; 2008 Oct; 86(8):1135-8. PubMed ID: 18946353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.